As has always been the case the weekly report information is used here. The data is up to and including April 30th/21- Even though that is not correct, due to the every constant two week lag.
*There have been a total of 4,548 reports (33.9 reports per 100,000 doses administered) up to and including April 30, 2021. Of the 4,548 reports, 748 were considered serious (5.6 reports per 100,000 doses administered).33.9 reports of adverse effects per 100,000. Let’s say 34 because that’s what it is. Nearly 6 in every 100,000 shots result in serious adverse effects. Of course what constitutes serious vs non serious is highly subjective. To give you all an example- Nausea and diarrhea would be considered non serious. However those effects can kill an elderly individual within a couple of days because of the resulting severe dehydration- Though death was the result, the claim would be of non serious side effects. Is that realistic to claim non serious?
* Up to and including April 30, 2021, there were 8 confirmed reports of Thrombosis with Thrombocytopenia, following vaccination with COVISHIELD/AstraZeneca in Canada.I’ve documented more cases of VITT here and there have been 3 deaths to date (remember lagging data provides an inaccurate report) One in Quebec, New Brunswick and Alberta.
*One individual died
- British Columbia, Canada 1st Vaccine Induced Thrombosis Case. Is it the First? Or the First Officially Acknowledged?
50 Dead this week- 50 Dead with Vaccine.
Up to and including April 30, 2021, a total of 50 reports identified deaths that occurred after the administration of a vaccine. Following medical case review using the WHO-UMC causality assessment categories, it has been determined that:
* 22 of these deaths are unlikely linked to a COVID-19 vaccine ( unlikely does not mean NOT LINKED)
* 25 are still under investigation
* 1 death was likely linked (refer to the Thrombosis with Thrombocytopenia Syndrome bullet above)
* 2 deaths were unclassifiable due to insufficient information available.
50 Dead with vaccine this week. And we know that is inaccurate because of data lag. The running total of deaths with vaccine is 258 + 50 = 308 That is 308 Deaths with Vaccine that never get mentioned. I should add, yes, it’s clear to me the total given for the weekly update is just that weekly. And a complete total is never provided, which is why it is provided here!
308 Dead with vaccine according to official stats.
This weeks inaccurate, but it’s all we have data, is based on a total of 1,893,260 injections which is DOWN from last week- explained below
The weekly data relates to the total weekly injections administered
* Last week 11,526,938 doses administered
* This week we have a total of 13,420,198 jabs
= Weekly injections tally is 1,893,260
That weekly total is down from last week’s high of 2,001,206
= 107,946 less shots administered
Perhaps this is why Canada suddenly wants to move to experimenting on minors?
* Canada is monitoring one safety issue
This is the VITT vs the innumerable VIT’s as Canada continues to play down vaccine harm
* 13,420,198 Total doses administered
* 4,548 Total adverse event following immunization reports (this number will change)
(0.034% of all doses administered)
* 3,800 Total adverse event following immunization reports that were non-serious (this number will change as well
(0.028% of all doses administered)
* 748 Total adverse event following immunization reports that were serious (0.006% of all doses administered)
* 261 New adverse event following immunization reports since last update (135 new non-serious and 126 new serious)
Now we get to the part of the report where we play catch up to some of the data lag:
By going back to last week's report we can see that the adverse reaction for the week ending April 16/21 totaled approximately 370 adverse event reports. With updated data that number jumps up to 435. That tells us an additional 60 + reports were entered.
If you wish to go back through all weekly reports see the links below:
- Is there honesty and transparency about what is known and what is not known?
"I think when you have no commercial experience with a vaccine strategy and you’re using that as a way to stop a new virus, there will be something of alearning curve. . . . I wish there was a little more humility from some of these companies. . . . You’re only going to know about rare adverse events once these vaccines are out there, because even in a best case scenario, they are tested on 20,000 or 30,000 people, not 20 million or 30 million people. So you are only going to know about a rare adverse event post-licensure. . . . When do you know enough to say that a vaccine’s benefits outweigh its theoretical risks? You have to also make sure people know what you don’t know. You don’t know how long protection is going to last. You’re only going to know that afterwards. You don’t know whether it causes a rare side effect. You’re only going to know that afterwards. . . . I just think we have to be honest and transparent about what we know and what we don’t know. Paul Offit, Setember, 2020.